in this issue
People & Business :: People/Executives
Codexis CEO Resigns
9:40 AM MST | February 21, 2012 | Rebecca Coons
Codexis CEO Alan Shaw resigned from his long-standing position at the enzyme developer to “pursue other interests,” sending stock prices 16% lower, to $3.81/share. Shaw has been with Codexis since its founding and was named CEO in 2002. He also led the enzyme maker through its 2010 initial public offering. Former senior v.p. and head of pharmaceuticals Peter Strumph will serve as interim CEO. Shaw’s departure closely follows news that CFO Bob Lawson will leave the company in following the company’s annual report filing. Market sources...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee